The creation of a donor-independent source of platelets has been challenging; however, recent advances show growing promise for alternative platelet sources. Pluripotent stem cells have the capacity to differentiate into mature megakaryocytes with the ability to produce functional platelets. In this issue of
Matthew C. Canver, Daniel E. Bauer, Stuart H. Orkin
Strategy for clinical scale production of platelets ex vivo.